Table 4.
Association Between Baseline LSM and Subsequent Risk of HCC in Patients With CLD
| Groups | Categories | Studies, n | Adjusted RR | 95% CI |
|---|---|---|---|---|
| Location | West | 4 | 1.06 | 1.01–1.12 |
| Asia | 5 | 1.18 | 1.05–1.32 | |
| Stage of CLD | All | 6 | 1.16 | 1.07–1.26 |
| Compensated cirrhosis | 3 | 1.04 | 1.00–1.09 | |
| Analysis | Adjusted | 7 | 1.08 | 1.05–1.12 |
| Unadjusted | 2 | 1.16 | 0.87–1.54 |
NOTE. The results represent change in risk of outcomes per unit (kPa) of LSM. All studies were performed in patients with viral hepatitis as the etiology of CLD, and all studies used TE as the modality for LSM.